Cargando…

Iron Oxide Nanoparticles as Theranostic Agents in Cancer Immunotherapy

Starting from the mid-1990s, several iron oxide nanoparticles (NPs) were developed as MRI contrast agents. Since their sizes fall in the tenths of a nanometer range, after i.v. injection these NPs are preferentially captured by the reticuloendothelial system of the liver. They have therefore been pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Canese, Rossella, Vurro, Federica, Marzola, Pasquina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399455/
https://www.ncbi.nlm.nih.gov/pubmed/34443781
http://dx.doi.org/10.3390/nano11081950

Ejemplares similares